|
Market Analysis Reports of alpha-Decitabine
|
Global Leukemia Drug Market, Drug Price, Patent, Dosage & Clinical Trials Insight 2025 Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. 'Global Leukemia Drug Market, Drug Price, Patent, Dosage & Clinical Trials Insight 2025' Report Highlights: Global Leukemia Drug Market Opportunity ...
2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... , Dalteparin, Danoprevir, Dapagliflozin, DARUNAVIR, DAS181, Decitabine, Deferiprone, Deferoxamine, Defibrotide, Degarelix, Dendrobium ... , Tetrandrine, thalidomide, Thymalfasin, Thymoquinone, Thymosin Alpha 1 , Tinzaparin , Tirofiban, TJ003234, TL-895, TMV ...
COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... , Dalteparin, Danoprevir, Dapagliflozin, DARUNAVIR, DAS181, Decitabine, Deferiprone, Deferoxamine, Defibrotide, Degarelix, Dendrobium ... , Tetrandrine, thalidomide, Thymalfasin, Thymoquinone, Thymosin Alpha 1 , Tinzaparin , Tirofiban, TJ003234, TL-895, TMV ...
US Blood Cancer Drug Market & Pipeline Analysis 2015 Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Pharmaceutical companies have identified the opportunities to generate significant revenues from blood cancer segment in US. Escalating blood ...
Epigenetic Drugs & Diagnostics Market ... covers DNA methylation inhibitors (e.g., azacitidine, decitabine), histone deacetylase (HDAC) inhibitors (e.g., vorinostat ... in seed and Series A funding from Alpha Wave Ventures, ARCH Venture Partners ...
|
|
|